tocophersolan has been researched along with baohuoside i in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, X; Lingling, C; Lv, H; Sun, E; Tan, X; Xin, J; Yan, C; Zhang, Z | 1 |
| Jia, XB; Jin, X; Sun, E; Tan, XB; Zhang, ZH; Zhu, FX | 1 |
| Huang, H; Jia, X; Song, J; Wei, Y; Xia, Z; Yan, H; Yao, N; Zhang, L; Zhang, Z | 1 |
| Jia, X; Song, J; Yan, H; Zhang, Z | 1 |
4 other study(ies) available for tocophersolan and baohuoside i
| Article | Year |
|---|---|
Influence of vitamin E tocopherol polyethylene glycol succinate 1000 on intestinal absorption of icariside II.
Topics: Algorithms; Animals; Caco-2 Cells; Chromatography, High Pressure Liquid; Colon; Electric Impedance; Flavonoids; Humans; Ileum; In Vitro Techniques; Intestinal Absorption; Male; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Vitamin E | 2012 |
A novel drug-phospholipid complex loaded micelle for baohuoside I enhanced oral absorption: in vivo and in vivo evaluations.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Caco-2 Cells; Chemical Phenomena; Drug Carriers; Drug Compounding; Drug Stability; Drugs, Chinese Herbal; Excipients; Flavonoids; Half-Life; Humans; Intestinal Absorption; Male; Micelles; Phospholipids; Polyethylene Glycols; Random Allocation; Rats; Solubility; Vitamin E | 2013 |
TPGS/Phospholipids Mixed Micelles for Delivery of Icariside II to Multidrug-Resistant Breast Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Inducing Factor; bcl-2-Associated X Protein; Breast Neoplasms; Caco-2 Cells; Caspases; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flavonoids; Humans; MCF-7 Cells; Mice; Mice, Nude; Micelles; Phospholipids; Proto-Oncogene Proteins c-bcl-2; Vitamin E | 2016 |
Hyaluronic acid-modified didecyldimethylammonium bromide/ d-a-tocopheryl polyethylene glycol succinate mixed micelles for delivery of baohuoside I against non-small cell lung cancer: in vitro and in vivo evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Flavonoids; Humans; Hyaluronic Acid; Inhibitory Concentration 50; Injections, Intravenous; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Micelles; Paclitaxel; Quaternary Ammonium Compounds; Solubility; Surface Properties; Technology, Pharmaceutical; Time Factors; Vitamin E; Xenograft Model Antitumor Assays | 2017 |